Logo image of ZOM

ZOMEDICA CORP (ZOM) Stock Price, Quote, News and Overview

NYSEARCA:ZOM - NYSE Arca - CA98980M1095 - Common Stock - Currency: USD

0.1198  0 (-0.66%)

After market: 0.1199 +0 (+0.08%)

ZOM Quote, Performance and Key Statistics

ZOMEDICA CORP

NYSEARCA:ZOM (2/21/2025, 8:04:00 PM)

After market: 0.1199 +0 (+0.08%)

0.1198

0 (-0.66%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High0.2
52 Week Low0.12
Market Cap117.40M
Shares979.95M
Float961.51M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-04 2025-03-04/amc
IPO10-28 2013-10-28


ZOM short term performance overview.The bars show the price performance of ZOM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6 -8 -10

ZOM long term performance overview.The bars show the price performance of ZOM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ZOM is 0.1198 USD. In the past month the price decreased by -3.7%. In the past year, price decreased by -3.78%.

ZOMEDICA CORP / ZOM Daily stock chart

ZOM Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.89 234.01B
ISRG INTUITIVE SURGICAL INC 80.74 211.07B
BSX BOSTON SCIENTIFIC CORP 41.63 154.00B
SYK STRYKER CORP 31.4 145.92B
MDT MEDTRONIC PLC 16.84 115.33B
BDX BECTON DICKINSON AND CO 16.35 65.30B
EW EDWARDS LIFESCIENCES CORP 27.98 43.23B
GEHC GE HEALTHCARE TECHNOLOGY 20.29 41.62B
IDXX IDEXX LABORATORIES INC 40.25 37.07B
DXCM DEXCOM INC 53.81 34.68B
RMD RESMED INC 26.21 34.03B
PHG KONINKLIJKE PHILIPS NVR- NY 17.5 24.02B

About ZOM

Company Profile

ZOM logo image Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company is headquartered in Ann Arbor, Michigan and currently employs 144 full-time employees. The company went IPO on 2013-10-28. The firm is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The firm's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.

Company Info

ZOMEDICA CORP

100 Phoenix Drive, Suite 125

Ann Arbor MICHIGAN 48108 US

CEO: Robert Cohen

Employees: 144

Company Website: https://zomedica.com/

Investor Relations: http://investors.zomedica.com

Phone: 17343692555

ZOMEDICA CORP / ZOM FAQ

What is the stock price of ZOMEDICA CORP today?

The current stock price of ZOM is 0.1198 USD. The price decreased by -0.66% in the last trading session.


What is the ticker symbol for ZOMEDICA CORP stock?

The exchange symbol of ZOMEDICA CORP is ZOM and it is listed on the NYSE Arca exchange.


On which exchange is ZOM stock listed?

ZOM stock is listed on the NYSE Arca exchange.


What is the price forecast or stock price prediction for ZOMEDICA CORP stock?

5 analysts have analysed ZOM and the average price target is 0.26 USD. This implies a price increase of 112.85% is expected in the next year compared to the current price of 0.1198. Check the ZOMEDICA CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ZOMEDICA CORP worth?

ZOMEDICA CORP (ZOM) has a market capitalization of 117.40M USD. This makes ZOM a Micro Cap stock.


How many employees does ZOMEDICA CORP have?

ZOMEDICA CORP (ZOM) currently has 144 employees.


What are the support and resistance levels for ZOMEDICA CORP (ZOM) stock?

ZOMEDICA CORP (ZOM) has a support level at 0.12 and a resistance level at 0.12. Check the full technical report for a detailed analysis of ZOM support and resistance levels.


Is ZOMEDICA CORP (ZOM) expected to grow?

The Revenue of ZOMEDICA CORP (ZOM) is expected to grow by 10.67% in the next year. Check the estimates tab for more information on the ZOM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ZOMEDICA CORP (ZOM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ZOMEDICA CORP (ZOM) stock pay dividends?

ZOM does not pay a dividend.


When does ZOMEDICA CORP (ZOM) report earnings?

ZOMEDICA CORP (ZOM) will report earnings on 2025-03-04, after the market close.


What is the Price/Earnings (PE) ratio of ZOMEDICA CORP (ZOM)?

ZOMEDICA CORP (ZOM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).


What is the Short Interest ratio of ZOMEDICA CORP (ZOM) stock?

The outstanding short interest for ZOMEDICA CORP (ZOM) is 4.64% of its float. Check the ownership tab for more information on the ZOM short interest.


ZOM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ZOM Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ZOM. No worries on liquidiy or solvency for ZOM as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ZOM Financial Highlights

Over the last trailing twelve months ZOM reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS decreased by -57.89% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -29.05%
ROE -30.66%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-900%
Sales Q2Q%10.29%
EPS 1Y (TTM)-57.89%
Revenue 1Y (TTM)11.33%

ZOM Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to ZOM. The Buy consensus is the average rating of analysts ratings from 5 analysts.

For the next year, analysts expect an EPS growth of -110.78% and a revenue growth 10.67% for ZOM


Ownership
Inst Owners9.39%
Ins Owners0.74%
Short Float %4.64%
Short Ratio7.82
Analysts
Analysts80
Price Target0.26 (117.03%)
EPS Next Y-110.78%
Revenue Next Year10.67%